JPM 2023 再生元.pdf

1、J.P.Morgan Healthcare ConferenceJ a n u a r y 9,2 0 2 3This non-promotional presentation contains investigational data as well as forward-looking statements;actual results may vary materially.J.P.Morgan Healthcare Conference 2023Strategy&Business Update2Leonard S.Schleifer,MD,PhDCo-Founder,President

2、&Chief Executive Officer3Note regarding forward-looking statements and non-GAAP financial measuresThis presentation includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals,Inc.(Regeneron or the Company

3、),and actual events or resultsmay differ materially from these forward-looking statements.Words such as anticipate,expect,intend,plan,believe,seek,estimate,variations of such words,and similar expressions are intended to identify such forward-lookingstatements,although not all forward-looking statem

4、ents contain these identifying words.These statements concern,and these risks and uncertainties include,among others,the impact of SARS-CoV-2(the virus that has caused the COVID-19pandemic)on Regenerons business and its employees,collaborators,and suppliers and other third parties on which Regeneron

5、 relies,Regenerons and its collaborators ability to continue to conduct research and clinical programs,Regenerons ability to manage its supply chain,net product sales of products marketed or otherwise commercialized by Regeneron and/or its collaborators or licensees(collectively,Regenerons Products)

6、,and the global economy;the nature,timing,and possible success and therapeutic applications of Regenerons Products and product candidates being developed by Regeneron and/or its collaborators or licensees(collectively,Regenerons Product Candidates)and research andclinical programs now underway or pl